These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Action of phosphatidylinositol specific phospholipase C on platelets: nonlytic release of acetylcholinesterase, effect on thrombin and PAF induced aggregation. Shukla SD. Life Sci; 1986 Feb 24; 38(8):751-5. PubMed ID: 3951330 [Abstract] [Full Text] [Related]
23. YD-3, a novel inhibitor of protease-induced platelet activation. Wu CC, Huang SW, Hwang TL, Kuo SC, Lee FY, Teng CM. Br J Pharmacol; 2000 Jul 24; 130(6):1289-96. PubMed ID: 10903968 [Abstract] [Full Text] [Related]
24. Protein kinase C delta specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation. Ettinger SL, Lauener RW, Duronio V. J Biol Chem; 1996 Jun 14; 271(24):14514-8. PubMed ID: 8663229 [Abstract] [Full Text] [Related]
30. Diversity of agonist-mediated signal transduction pathways in human platelets. Saeed SA, Shah BH. Adv Exp Med Biol; 1997 Jun 14; 407():531-5. PubMed ID: 9322003 [No Abstract] [Full Text] [Related]
31. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. Kulikov VI, Muzya GI. Biochemistry (Mosc); 2000 Apr 14; 65(4):427-30. PubMed ID: 10810178 [Abstract] [Full Text] [Related]
32. Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. Pigazzi A, Heydrick S, Folli F, Benoit S, Michelson A, Loscalzo J. J Biol Chem; 1999 May 14; 274(20):14368-75. PubMed ID: 10318860 [Abstract] [Full Text] [Related]